Bullish Moving Averages
15
Bearish Moving Averages
1
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
652.00Today’s High
673.6052W low
392.0052W High
755.20Open Price
672.40Prev. Close
581.4500Volume
69294.00Value
45342528.90Fundamentals
Market Cap
1310.60
Price to Earnings
14.00
Price to Book Value
2.20
Dividend Yield
0.20
PE to Growth
0.50
Op Revenue TTM
580.55
Net Profit TTM
93.30
Cash From Operating Activity
63.22
Return on Equity %
15.73
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
51.8
Week
40.2
Month
48.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
659.97
PIVOT
First Resistance
667.93
Second Resistance
681.52
Third Resistance
689.48
First Support
646.38
Second Support
638.42
Third Support
624.83
Relative Strength Index
65.68
Money Flow Index
77.46
MACD
18.11
MACD Signal
13.2
Average True Range
19.6
Average Directional Index
29.15
Rate of Change (21)
15.62
Rate of Change (125)
0.69
Commodity Channel Index
146.4
Williams %R
-34.9
BETA
1 Month
1.45
3 Month
0.93
1 Year
0.63
3 Year
0.27
PRICE CHANGE ANALYSIS
↑ 6.76%
1 Week
Low
High
614
686.95
↑ 15.62%
1 Month
Low
High
564.95
686.95
↑ 6.17%
3 Months
Low
High
534.8
686.95
↑ 1.16%
6 Months
Low
High
534.8
755.15
↑ 57.16%
1 Year
Low
High
391.95
755.15
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 149.51 | 157.47 | 164.68 | 143.31 | 116.41 | 140.12 | 146.30 | 129.97 | 104.43 | 122.52 | 129.41 | |
| Operating Expenses Qtr | 124.11 | 116.79 | 124.84 | 114.90 | 95.86 | 107.02 | 111.70 | 106.56 | 85.11 | 96.43 | 97.46 | |
| Operating Profit Qtr | 18.38 | 29.66 | 31.15 | 20.72 | 16.60 | 26.75 | 28.91 | 16.91 | 17.44 | 23.45 | 28.18 | |
| EBIDT Qtr Cr | 25.40 | 40.68 | 39.84 | 28.41 | 20.54 | 33.11 | 34.59 | 23.41 | 19.33 | 26.09 | 31.95 | |
| Depreciation Qtr | 2.69 | 2.81 | 2.58 | 2.55 | 2.41 | 2.26 | 2.42 | 2.07 | 2.00 | 2.18 | 1.51 | |
| Net Profit Qtr | 18.60 | 28.04 | 27.65 | 19.01 | 12.56 | 21.61 | 23.71 | 15.01 | 11.02 | 17.60 | 22.88 | |
| Basic EPS Qtr | 9.28 | 14.00 | 13.81 | 9.49 | 6.27 | 10.79 | 11.84 | 7.49 | 5.50 | 8.79 | 11.44 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 614.97 | 532.79 | 482.08 | 419.82 | 388.22 | |
| Operating Expenses Annual Cr | 480.64 | 421.14 | 376.61 | 331.71 | 316.72 | |
| Operating Profit Annual | 99.91 | 89.17 | 95.47 | 81.35 | 59.37 | |
| Operating Profit Margin Annual % | 16.25 | 16.74 | 19.80 | 19.38 | 15.29 | |
| Total Expenses Annual Cr | 492.73 | 432.34 | 386.15 | 338.81 | 324.17 | |
| EBIDT Annual Cr | 134.33 | 111.65 | 105.47 | 88.12 | 71.50 | |
| EBIDT Annual margin % | 21.84 | 20.96 | 21.88 | 20.99 | 18.42 | |
| Depreciation | 10.62 | 9.17 | 8.09 | 5.67 | 5.47 | |
| PAT Before ExtraOrdinary Items Annual Cr | 93.30 | 72.90 | 69.36 | 60.41 | 49.56 | |
| Net Profit Annual | 93.30 | 72.90 | 69.36 | 60.41 | 49.56 | |
| Basic EPS Annual | 46.58 | 36.40 | 34.63 | 30.20 | 24.78 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 592.84 | 502.47 | 432.88 | 364.95 | 304.49 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 15.18 | 12.66 | 10.99 | 7.69 | 7.24 | |
| Total Current Liabilities Annual Cr | 92.14 | 72.12 | 90.24 | 66.04 | 55.47 | |
| Total Capital Plus Liabilities Annual Cr | 700.15 | 587.26 | 534.11 | 438.69 | 367.21 | |
| Fixed Assets Annual | 182.81 | 157.24 | 147.93 | 91.24 | 91.07 | |
| Total Non Current Assets Annual | 253.60 | 220.26 | 181.56 | 162.97 | 151.83 | |
| Total Current Assets Annual | 446.55 | 367.00 | 352.56 | 275.72 | 215.38 | |
| Total Assets Annual | 700.15 | 587.26 | 534.11 | 438.69 | 367.21 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 2.68 | 2.47 | 7.28 | 2.26 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 63.24 | 39.16 | 76.18 | 71.41 | 70.71 | |
| Cash from Investing Activity Annual | -57.34 | -36.64 | -78.08 | -64.91 | -28.99 | |
| Cash from Financing Annual Activity | -5.18 | -4.50 | -2.56 | -5.29 | -38.10 | |
| Net Cash Flow Annual | - | -1.99 | -4.46 | 1.20 | 3.61 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 295.98 | 250.86 | 216.12 | 182.48 | 152.25 | |
| ROE Annual % | 15.73 | 14.50 | 16.02 | 16.55 | 16.27 | |
| ROCE Annual % | 20.34 | 19.89 | 21.93 | 22.12 | 21.18 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| EBDIT Annual Margin % | 23.13 | 21.87 | 22.34 | 21.33 | 19.01 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 149.51 | 157.47 | 164.68 | 143.31 | 116.36 | 140.12 | 146.33 | 129.97 | 104.48 | |
| Operating Expenses Qtr | 124.11 | 116.79 | 124.84 | 114.90 | 95.82 | 107.02 | 111.71 | 106.56 | 85.14 | |
| Operating Profit Qtr | 18.38 | 29.66 | 31.15 | 20.72 | 16.64 | 26.75 | 28.90 | 16.91 | 17.45 | |
| EBIDT Qtr Cr | 25.40 | 40.68 | 39.84 | 28.41 | 20.54 | 33.11 | 34.62 | 23.41 | 19.34 | |
| Depreciation Qtr | 2.69 | 2.81 | 2.58 | 2.55 | 2.41 | 2.26 | 2.42 | 2.07 | 2.00 | |
| Net Profit Qtr | 18.60 | 28.04 | 27.65 | 19.01 | 12.56 | 21.61 | 23.71 | 15.01 | 11.02 | |
| Basic EPS Qtr | 9.28 | 14.00 | 13.81 | 9.49 | 6.27 | 10.79 | 11.84 | 7.49 | 5.50 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 614.97 | 532.78 | 482.12 | 429.85 | 397.53 | |
| Operating Expenses Annual Cr | 480.64 | 421.11 | 376.64 | 337.01 | 320.95 | |
| Operating Profit Annual | 99.91 | 89.20 | 95.48 | 87.18 | 65.54 | |
| Operating Profit Margin Annual % | 16.25 | 16.74 | 19.80 | 20.28 | 16.49 | |
| Total Expenses Annual Cr | 492.73 | 432.30 | 386.18 | 346.13 | 330.30 | |
| EBIDT Annual Cr | 134.33 | 111.68 | 105.48 | 92.84 | 76.58 | |
| EBIDT Annual margin % | 21.84 | 20.96 | 21.88 | 21.60 | 19.26 | |
| Depreciation | 10.62 | 9.17 | 8.09 | 7.56 | 7.33 | |
| PAT Before ExtraOrdinary Items Annual Cr | 93.30 | 72.90 | 69.36 | 62.25 | 51.47 | |
| Net Profit Annual | 93.30 | 72.90 | 69.36 | 62.22 | 51.44 | |
| Basic EPS Annual | 46.58 | 36.40 | 34.63 | 31.11 | 25.72 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 592.84 | 502.47 | 432.88 | 375.29 | 313.09 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.41 | 0.38 | |
| Total Non Current Liabilities Annual Cr | 15.18 | 12.66 | 10.99 | 10.13 | 10.33 | |
| Total Current Liabilities Annual Cr | 92.28 | 72.28 | 90.49 | 73.55 | 65.58 | |
| Total Capital Plus Liabilities Annual Cr | 700.29 | 587.42 | 534.36 | 459.37 | 389.39 | |
| Fixed Assets Annual | 182.81 | 157.24 | 147.93 | 112.32 | 113.53 | |
| Total Non Current Assets Annual | 253.55 | 220.21 | 181.51 | 152.92 | 141.39 | |
| Total Current Assets Annual | 446.74 | 367.21 | 352.85 | 306.46 | 248.00 | |
| Total Assets Annual | 700.29 | 587.42 | 534.36 | 459.37 | 389.39 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 2.68 | 2.47 | 7.31 | 2.37 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 63.22 | 39.26 | 76.13 | 69.27 | 75.42 | |
| Cash from Investing Activity Annual | -57.34 | -36.64 | -78.08 | -64.23 | -30.88 | |
| Cash from Financing Annual Activity | -5.18 | -4.50 | -2.56 | -5.75 | -37.76 | |
| Net Cash Flow Annual | - | -1.88 | -4.50 | -0.70 | 6.77 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 295.98 | 250.86 | 216.12 | 187.85 | 156.74 | |
| ROE Annual % | 15.73 | 14.50 | 16.02 | 16.58 | 16.42 | |
| ROCE Annual % | 20.34 | 19.89 | 21.94 | 22.10 | 21.38 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| EBDIT Annual Margin % | 23.13 | 21.88 | 22.34 | 21.88 | 19.81 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Dheeraj Kumar Lohia | 1.32 | 75037504 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Munjal Mahendrabhai Patel | 13.13 | 75037460 | 0 | 0 |
| Aashish Rajanibhai Patel | 10.6 | 75037461 | 0 | 0 |
| Rajanikant Gulabdas Patel | 3.78 | 75037462 | 0 | 0 |
| Mahendrabhai Gulabdas Patel | 3.37 | 75037463 | 0 | 0 |
| Kailashben Mahendrabhai Patel | 2.4 | 75037464 | 0 | 0 |
| Hashmukhbhai Ishwarlal Patel | 1.87 | 75037465 | 0 | 0 |
| Anand Arvinbhai Patel | 1.66 | 75037466 | 0 | 0 |
| Shivani B. Shah | 1.03 | 75037467 | 0 | 0 |
| Mansi Munjal Patel | 1 | 75037468 | 0 | 0 |
| Hansaben Arvindbhai Patel | 0.88 | 75037469 | 0 | 0 |
| Patel Nishitkumar Maheshbhai | 0.77 | 75037470 | 0 | 0 |
| Dharmisthaben Bhagirath Patel | 0.62 | 75037471 | 0 | 0 |
| Arvindbhai Gulabdas Patel | 0.55 | 75037472 | 0 | 0 |
| Sunmed Corporation Llp | 2.5 | 75037487 | 0 | 0 |
| Downtown Travels Llp | 2.37 | 75037488 | 0 | 0 |
| Downtown Finance Pvt. Ltd. | 0.53 | 75037489 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Rimo Capital Fund Lp | 1.25 | 75037495 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Dheeraj Kumar Lohia | 1.32 | 75037504 |
| Kamlesh Jayantilal Patel | 1.09 | 75037505 |
| HUF | 2.54 | 75037497 |
| Parikh Mitesh Jagdishbhai | 1.01 | 75037498 |
| Kishor M. Shah | 2.39 | 75037510 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 15, 2023 | 1.5 | FINAL | - | Equity Share |
| Sep 15, 2022 | 1.5 | FINAL | - | Equity Share |
| Sep 16, 2021 | 1.5 | FINAL | - | Equity Share |
| Mar 05, 2020 | 1.5 | INTERIM | Mar 06, 2020 | Equity Share |
| Sep 19, 2019 | 1.5 | FINAL | - | Equity Share |
| Sep 19, 2018 | 1.5 | FINAL | - | Equity Share |
| Sep 21, 2017 | 1.2 | FINAL | - | Equity Share |
| Sep 23, 2016 | 1 | FINAL | - | Equity Share |
| Sep 23, 2015 | 1 | FINAL | - | Equity Share |
| Sep 25, 2014 | 0.6 | FINAL | - | Equity Share |
| Sep 19, 2013 | 0.6 | FINAL | - | Equity Share |
| Sep 20, 2012 | 0.6 | FINAL | - | Equity Share |
| Sep 22, 2011 | 0.6 | FINAL | - | Equity Share |
| Sep 23, 2010 | 1.2 | FINAL | - | Equity Share |
| Sep 17, 2009 | 1.2 | FINAL | - | Equity Share |
| Sep 18, 2008 | 0.24 | FINAL | - | Equity Share |
| Sep 20, 2007 | 0.24 | FINAL | - | Equity Share |
| Sep 14, 2006 | 0.24 | FINAL | - | Equity Share |
| Aug 25, 2005 | 1.2 | FINAL | - | Equity Share |
| Sep 17, 2004 | 1.2 | FINAL | - | Equity Share |
| Sep 22, 2003 | 1.2 | FINAL | - | Equity Share |
| Sep 23, 2002 | 1 | FINAL | - | Equity Share |
| Sep 11, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Mar 19, 2009 | 2:10 | 2009-03-26 |
| Feb 08, 2006 | 10:2 | 2006-02-16 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 16, 2024 | Audited Results & Final Dividend | - |
| Feb 08, 2024 | Quarterly Results | - |
| Nov 02, 2023 | Quarterly Results | - |
| Aug 10, 2023 | Quarterly Results | - |
| May 25, 2023 | Audited Results & Dividend | - |
| Feb 09, 2023 | Quarterly Results | - |
| Nov 10, 2022 | Quarterly Results | - |
| Aug 09, 2022 | Quarterly Results | - |
| May 19, 2022 | Audited Results & Dividend | - |
| Feb 10, 2022 | Quarterly Results | - |
| Nov 11, 2021 | Quarterly Results | - |
| Oct 05, 2021 | Others | inter-alia, 1) To issue/ allot equity shares to the eligible shareholders of Lincoln Parenteral Ltd. pursuant to Scheme of Amalgamation. |
| Aug 10, 2021 | Quarterly Results | - |
| May 25, 2021 | Audited Results & Dividend | - |
| Feb 02, 2021 | Quarterly Results | - |
| Nov 03, 2020 | Quarterly Results | - |
| Jun 25, 2020 | Audited Results | - |
| Feb 27, 2020 | Interim Dividend | - |
| Feb 13, 2020 | Quarterly Results | - |
| Dec 07, 2019 | Others | Inter alia, To consider and approve draft scheme of amalgamation of Lincoln Parenteral Limited with Lincoln Pharmaceuticals Limited |
| Nov 14, 2019 | Quarterly Results | - |
| Sep 19, 2019 | Amalgamation | inter alia, to consider and approve Draft scheme of amalgamation of Lincoln Parenteral Limited ('The Transferor Company') with Lincoln Pharmaceuticals Limited ('The Transferee Company') |
| Aug 14, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results & Dividend | - |
| Mar 28, 2019 | Others | inter alia, 1. To appoint Chief Financial Officer (CFO] (Key Managerial Personnel] of the Company. 2. To appoint Secretarial Auditors of the Company for the F.Y. 2018-19. |
| Feb 12, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Half Yearly Results | - |
| Aug 14, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results & Dividend | - |
| Mar 27, 2018 | Others | Appointed Mr. Saurin J. Parikh as an Additional Director (categorised as an Independent Director) on the Board of the Company. |
| Jan 31, 2018 | Quarterly Results | - |
| Dec 12, 2017 | Quarterly Results | - |
| Sep 14, 2017 | Quarterly Results | - |
| May 30, 2017 | Audited Results & Dividend | - |
| Feb 09, 2017 | Quarterly Results | - |
| Nov 10, 2016 | Quarterly Results & Others | Delisting of Equity Shares of the Company from Ahmedabad Stock Exchange Limited pursuant to SEBI (Delisting of Equity Shares) Regulations, 2009. As amended from time to time. |
| Oct 27, 2016 | Others | To issue and allotment of equity shares against conversion of warrant issue to Promoter/Promoter Group and Non-Promoter warrant holders. |
| Aug 11, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results & Dividend | - |
| Feb 11, 2016 | Quarterly Results | - |
| Nov 05, 2015 | Quarterly Results | - |
| Aug 04, 2015 | Quarterly Results | Appointed Ms. Meha Patel as an Additional Director (Women Director) to be categorized as an Independent Director. |
| Jul 07, 2015 | Others | To consider the appointment of new Statutory Auditors in place of existing Statutory Auditors to fill the casual vacancy |
| May 30, 2015 | Issue of convertible warrants | - |
| Apr 16, 2015 | Issue of convertible warrants | - |
| Feb 13, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| Aug 14, 2014 | Quarterly Results | - |
| May 30, 2014 | Audited Results & Dividend | - |
| Feb 13, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Aug 13, 2013 | Quarterly Results | - |
| May 30, 2013 | Audited Results & Dividend | - |
| Feb 12, 2013 | Quarterly Results | - |
| Nov 08, 2012 | Quarterly Results | - |
| Aug 14, 2012 | Audited, Quarterly Results & Dividend | For the quarter ended on 30.06.2012 & for the year 2011-12. |
| Feb 14, 2012 | Quarterly Results | - |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 12, 2011 | Quarterly Results | - |
| May 30, 2011 | Audited Results & Dividend | - |
| May 12, 2011 | Quarterly Results | - |
| Feb 12, 2011 | Quarterly Results | - |
| Nov 12, 2010 | Quarterly Results | - |
| Oct 15, 2010 | Preferential Issue of Shares | - |
| Aug 31, 2010 | Increase in Authorised Capital & Others | The Board has approved to increase the Authorized Share Capital from Rs. 12 Cr to Rs. 20 Cr & to issue of 50,00,000 Equity Shares of Rs. 10/- each on pref. basis as per SEBI (ICDRs) Regulations 2009. |
| Aug 19, 2010 | Audited Results & Dividend | To fix record date for the purpose of AGM and dividend, if any. |
| Jul 30, 2010 | Quarterly Results | - |
| Apr 29, 2010 | Quarterly Results | - |
| Mar 31, 2010 | Shifting of registered office of the Co. | The Board has shifted the registered office of the Company to "LINCOLN HOUSE", B/H. Satyam Complex, Science City Road, Sola, Ahmedabad - 380 060, Gujarat & T.N. 079-30018000, Fax. 079-30018062. |
| Jan 28, 2010 | Quarterly Results | - |
| Jan 20, 2010 | Allotment of Equity Shares | The Board has allotted 13,00,000 Equity Shares of FV of Rs. 10/- each for cash at premium of Rs. 40/- per Share to the 4 different entities on a pref. basis against CW's allotted on July 21, 2008. |
| Oct 30, 2009 | Quarterly Results | - |
| Oct 15, 2009 | Allotment of Equity Shares | The Board has allotted 24,00,000 Equity Shares of Rs. 10/- each for cash at premium of Rs. 17/- per share to the six different entities on a preferential basis. |
| Aug 31, 2009 | Audited Results, Dividend & Others | To increase in Authorised Share Capital from Rs 10 Crs to Rs 12 Crs & to issue of 24,00,000 Equity Shares of Rs. 10/- each on preferential basis to promoters groups & other than promoters group. |
| Jul 30, 2009 | Quarterly Results | - |
| Apr 30, 2009 | Quarterly Results | - |
| Jan 29, 2009 | Quarterly Results & Others | To determine record date to consolidate share of face value of Rs 2/- each in to share of face value of Rs 10/- each. |
| Oct 21, 2008 | Quarterly Results | - |
| Aug 20, 2008 | Audited Results, Dividend & Others | To consolidate the equity shares of face value of Rs 2/- each to face value of Rs 10/- each subject to approval of shareholders at ensuing AGM. |
| Jul 21, 2008 | Quarterly Results & Others | To issue 1,00,00,000 (One Crore) warrants convertible into equity shares of Rs 2/- each at a premium of Rs 8/- per share, pursuant to "in-principal" approval received from stock exchanges. |
| Apr 24, 2008 | Quarterly Results & Others | inter alia, to consider and decide about issue of Warrants convertible in to shares and / or Equity shares to promoters group / persons other than promoters group as per SEBI (DIP) Guidelines. |
| Jan 17, 2008 | Quarterly Results | - |
| Oct 30, 2007 | Quarterly Results | - |
| Aug 30, 2007 | Audited Results & Dividend | - |
| Jul 26, 2007 | Quarterly Results | - |
| Apr 26, 2007 | Quarterly Results | - |
| Jan 27, 2007 | Quarterly Results | - |
| Oct 31, 2006 | Quarterly Results | - |
| Oct 10, 2006 | Others | To consider the matter the issue of equity shares (Face Value of Rs 2/- per share) not exceeding 7,60,000 shares on Preferential basis at price not less than Rs 20/- per share. |
| Aug 31, 2006 | Accounts & Dividend | - |
| Jul 27, 2006 | Quarterly Results | - |
| Apr 24, 2006 | Quarterly Results | - |
| Jan 24, 2006 | Quarterly Results | - |
| Dec 19, 2005 | Sub Division of Equity shares | - |
| Oct 03, 2005 | Quarterly Results | - |
| Aug 11, 2005 | Accounts & Dividend | - |
| Jul 28, 2005 | Quarterly Results | - |
| Jul 14, 2005 | Preferential Issue of shares | to make allotment of 16,10,000 equity shaes. |
| Jun 02, 2005 | Preferential Issue of shares | & Increase in Authorised Capital from Rs.7 crores to Rs.9 crores |
| Apr 30, 2005 | Quarterly Results & Pref. Issue | Preferential Issue of shares |
| Jan 31, 2005 | Quarterly Results | - |
| Oct 15, 2004 | Quarterly Results | To consider the reissue of 2,13,100 forfeited Equity shares. |
| Aug 19, 2004 | Accounts, Dividend & Others | To consider the re-issue of 2,13,100 forfeited equity shares. |
| Jul 27, 2004 | Quarterly Results | - |
| Apr 29, 2004 | Quarterly Results | - |
| Feb 21, 2004 | General | 1) To issue 2,13,100 forfeited shares. 2) To make preferential allotment of equity shares as may be decided by the BOD. |
| Jan 06, 2004 | Quarterly Results | - |
| Oct 06, 2003 | Quarterly Results | - |
| Jul 30, 2003 | Quarterly Results | - |
| Apr 29, 2003 | Quarterly Results | - |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 30, 2002 | Quarterly Results | - |
| Aug 12, 2002 | Accounts | - |
| Jul 31, 2002 | Quarterly Results | - |
| Apr 30, 2002 | Accounts & Quarterly Results | - |
| Jan 31, 2002 | Quarterly Results | - |
| Oct 31, 2001 | Half Yearly Results & Quarterly Results | - |
| Aug 23, 2001 | Dividend & Accounts | - |
| Jul 30, 2001 | Quarterly Results | - |
| Apr 30, 2001 | Quarterly Results | - |
| Jan 31, 2001 | Quarterly Results | - |
| Oct 19, 2000 | Quarterly Results | - |
| Jul 29, 2000 | Accounts, Div. & Quarterly Resuts (Revis | - |
| Apr 27, 2000 | Quarterly Results | - |
| Jan 31, 2000 | Quarterly Results | - |
| Oct 30, 1999 | Quarterly Results | - |
| Apr 29, 1999 | Unaudited Financial Results | - |
| Jan 28, 1999 | Quarterly Results | - |
| Oct 30, 1998 | Quarterly Results & Half Yearly Results | - |
| Jul 30, 1998 | Quarterly Results | - |
| Nov 20, 1997 | Half Yearly Results | - |
| Jun 28, 1997 | Accounts & Dividend. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
06 Jul 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We hereby submit the confirmation certificate as received from M/S Link Intime India Private Limited, Registrar and Share Transfer Agent for the Quarter Ended June 30, 2024.
26 Jun 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Closure of Trading Window
Intimation of Closure of Trading Window for the Quarter ended June 30, 2024.
11 Jun 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs
03 Jun 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs
24 May 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year Ended March 31, 2024.
20 May 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Outcome of Postal Ballot- Voting Results and Scrutinizer Report
20 May 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Outcome of Postal Ballot-Voting Results and Scrutinizer Report
18 May 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , we attach herewith transcript of Conference Call held on May 16, 2024 . A copy of the same is available on the website of the Company.
17 May 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2024.
16 May 2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
We wish to inform you that the Company participated in investor conference- Call Conference on May 16, 2024. No Unpublished Price Sensitive Information (UPSI) was shared / discussed in the meeting with investors.
